COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 243.0 | 5 | 0097-0354 | 761.47 | 354.39 | 397 | 77.84 | 0.823 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 196.1 | 5 | 0098-0359 | 854.76 | 359.24 | 407 | 77.50 | 0.852 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 262.8 | 5 | 0099-0360 | 135.44 | 360.45 | 392 | 76.91 | 0.833 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 383.4 | 5 | 0100-0363 | 589.18 | 362.90 | 402 | 74.43 | 0.912 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 616.2 | 5 | 0101-0367 | 273.26 | 367.66 | 450 | 81.74 | 0.846 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 247.8 | 5 | 0102-0365 | 897.87 | 364.97 | 378 | 73.26 | 0.885 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 398.7 | 5 | 0103-0376 | 484.26 | 375.96 | 819 | 108.71 | 0.871 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 249.4 | 5 | 0104-0375 | 377.85 | 374.63 | 416 | 78.08 | 0.857 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 677.5 | 5 | 0105-0378 | 304.46 | 378.42 | 424 | 78.67 | 0.861 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 716.5 | 5 | 0106-0380 | 40.49 | 380.98 | 425 | 78.67 | 0.863 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 238.5 | 5 | 0107-0386 | 833.52 | 386.16 | 399 | 75.84 | 0.872 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 294.9 | 5 | 0108-0388 | 630.64 | 387.98 | 450 | 82.33 | 0.834 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 280.3 | 5 | 0109-0396 | 411.42 | 396.40 | 397 | 76.08 | 0.862 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 259.4 | 5 | 0110-0401 | 740.54 | 401.57 | 418 | 77.84 | 0.867 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 274.9 | 5 | 0111-0404 | 366.68 | 404.38 | 414 | 76.67 | 0.885 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 208.5 | 5 | 0112-0406 | 217.90 | 406.82 | 369 | 74.67 | 0.832 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 249.7 | 5 | 0113-0408 | 175.02 | 408.75 | 399 | 76.91 | 0.848 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 352.3 | 5 | 0114-0411 | 715.24 | 410.60 | 451 | 84.33 | 0.797 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 237.5 | 5 | 0115-0412 | 535.17 | 412.48 | 466 | 85.15 | 0.808 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 284.6 | 5 | 0116-0418 | 907.23 | 417.81 | 194 | 52.53 | 0.884 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 985.5 | 5 | 0117-0426 | 802.16 | 426.03 | 435 | 81.74 | 0.818 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 245.3 | 5 | 0118-0427 | 257.71 | 426.72 | 386 | 73.84 | 0.890 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 282.8 | 5 | 0119-0427 | 610.99 | 426.01 | 452 | 86.57 | 0.758 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 227.8 | 5 | 0120-0427 | 511.47 | 427.34 | 436 | 80.91 | 0.837 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 547.9 | 5 | 0121-0426 | 869.44 | 427.90 | 301 | 66.28 | 0.861 |